Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Peripheral blood RNA expression profiling in illicit methcathinone users reveals effect on immune system.

Sikk K, Kõks S, Soomets U, Schalkwyk LC, Fernandes C, Haldre S, Aquilonius SM, Taba P.

Front Genet. 2011 Aug 19;2:42. doi: 10.3389/fgene.2011.00042. eCollection 2011.

2.

A Parkinsonian syndrome in methcathinone users and the role of manganese.

Stepens A, Logina I, Liguts V, Aldins P, Eksteina I, Platkājis A, Mārtinsone I, Tērauds E, Rozentāle B, Donaghy M.

N Engl J Med. 2008 Mar 6;358(10):1009-17. doi: 10.1056/NEJMoa072488.

3.

Grey matter abnormalities in methcathinone abusers with a Parkinsonian syndrome.

Juurmaa J, Menke RA, Vila P, Müürsepp A, Tomberg T, Ilves P, Nigul M, Johansen-Berg H, Donaghy M, Stagg CJ, Stepens A, Taba P.

Brain Behav. 2016 Aug 18;6(11):e00539. eCollection 2016 Nov.

4.

The outcome of the movement disorder in methcathinone abusers: clinical, MRI and manganesemia changes, and neuropathology.

Stepens A, Groma V, Skuja S, Platkājis A, Aldiņš P, Ekšteina I, Mārtiņsone I, Bricis R, Donaghy M.

Eur J Neurol. 2014 Feb;21(2):199-205. doi: 10.1111/ene.12185. Epub 2013 May 17.

PMID:
23678867
5.

Urine as a material for evaluation of exposure to manganese in methcathinone users.

Golasik M, Wodowski G, Gomółka E, Herman M, Piekoszewski W.

J Trace Elem Med Biol. 2014 Jul;28(3):338-43. doi: 10.1016/j.jtemb.2014.04.005. Epub 2014 May 4.

PMID:
24867657
6.

Peripheral blood RNA gene expression profiling in patients with bacterial meningitis.

Lill M, Kõks S, Soomets U, Schalkwyk LC, Fernandes C, Lutsar I, Taba P.

Front Neurosci. 2013 Mar 18;7:33. doi: 10.3389/fnins.2013.00033. eCollection 2013.

7.

Manganese-induced parkinsonism in methcathinone abusers: bio-markers of exposure and follow-up.

Sikk K, Haldre S, Aquilonius SM, Asser A, Paris M, Roose Ä, Petterson J, Eriksson SL, Bergquist J, Taba P.

Eur J Neurol. 2013 Jun;20(6):915-20. doi: 10.1111/ene.12088. Epub 2013 Jan 24.

PMID:
23347399
8.

Methcathinone "Kitchen Chemistry" and Permanent Neurological Damage.

Sikk K, Taba P.

Int Rev Neurobiol. 2015;120:257-71. doi: 10.1016/bs.irn.2015.02.002. Epub 2015 Mar 12. Review.

PMID:
26070761
9.

Increased striatal VMAT2 binding in mice after chronic administration of methcathinone and manganese.

Asser A, Kõks S, Snellman A, Haaparanta-Solin M, Arponen E, Grönroos T, Nairismägi J, Bergquist J, Soomets U, Piip P, Eltermaa M, Sauk M, Lindmäe H, Rinne JO, Taba P.

Brain Res. 2016 Dec 1;1652:97-102. doi: 10.1016/j.brainres.2016.09.034. Epub 2016 Sep 28.

PMID:
27693414
10.

Methcathinone: a new postindustrial drug.

Belhadj-Tahar H, Sadeg N.

Forensic Sci Int. 2005 Oct 4;153(1):99-101.

PMID:
15919169
11.
12.

[Encephalopathy caused by intravenous potassium permanganate used for illegal production of methcathinone (ephedrone) from medicines containing pseudoephedrine].

Habrat B, Baran-Furga H, Sienkiewicz-Jarosz H, Sein Anand J, Poniatowska R.

Przegl Lek. 2013;70(8):613-6. Review. Polish.

PMID:
24466704
13.

Manganese Encephalopathy among Ephedron Abusers.

Janocha-Litwin J, Marianska K, Serafinska S, Simon K.

J Neuroimaging. 2015 Sep-Oct;25(5):832-5. doi: 10.1111/jon.12173. Epub 2014 Sep 26.

PMID:
25255816
14.

Intravenous self-injection of methcathinone in the baboon.

Kaminski BJ, Griffiths RR.

Pharmacol Biochem Behav. 1994 Apr;47(4):981-3.

PMID:
8029273
15.

White matter abnormalities in methcathinone abusers with an extrapyramidal syndrome.

Stepens A, Stagg CJ, Platkajis A, Boudrias MH, Johansen-Berg H, Donaghy M.

Brain. 2010 Dec;133(Pt 12):3676-84. doi: 10.1093/brain/awq281. Epub 2010 Oct 29.

16.
17.

Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors.

Loebstein R, Mahagna R, Maor Y, Kurnik D, Elbaz E, Halkin H, Olchovsky D, Ezra D, Almog S.

Isr Med Assoc J. 2008 Nov;10(11):775-8.

18.

Claudin-1 gene variants and susceptibility to hepatitis C infection in HIV-1 infected intravenous drug users (an ANRS case-control study).

Ghosn J, Fouquet B, Quertainmont Y, Salmon D, Sahali S, Rioux C, Duvivier C, Mole M, Delfraissy JF, Misrahi M.

J Med Virol. 2015 Apr;87(4):619-24. doi: 10.1002/jmv.24088. Epub 2015 Jan 21.

PMID:
25611191
19.

The impact of chronic hepatitis C virus infection on HIV disease and progression in intravenous drug users.

Haydon GH, Flegg PJ, Blair CS, Brettle RP, Burns SM, Hayes PC.

Eur J Gastroenterol Hepatol. 1998 Jun;10(6):485-9.

PMID:
9855064
20.

Neurotoxicity following chronic intravenous use of "Russian cocktail".

Varlibas F, Delipoyraz I, Yuksel G, Filiz G, Tireli H, Gecim NO.

Clin Toxicol (Phila). 2009 Feb;47(2):157-60. doi: 10.1080/15563650802010388.

PMID:
18608260

Supplemental Content

Support Center